Circulating cell-free DNA of methylated insulin-like growth factor-binding protein 7 predicts a poor prognosis in hepatitis B virus-associated hepatocellular carcinoma after hepatectomy

References

• Bosch FX, Ribes J, Cléries R, et al. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2005;9(2):191–211.
   PubMedGoogle Scholar
• Yuen MF, Hou JL, Chutaputti A, et al. Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol. 2009;24(3):346–353.
   PubMed Web of Science ®Google Scholar
• Gao H, Li K, Tu H, et al. Development of T cells redirected to glypican-3 for the treatment of hepatocellular carcinoma. Clin Cancer Res. 2014;20(24):6418–6428.
   PubMed Web of Science ®Google Scholar
• Franco R, Schoneveld O, Georgakilas AG, et al. Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett. 2008;266(1):6–11.
   PubMed Web of Science ®Google Scholar
• Ziech D, Franco R, Pappa A, et al. Reactive oxygen species (ROS) – induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res. 2011;711(1–2):167–173.
   PubMed Web of Science ®Google Scholar
• Herceg Z, Paliwal A. Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome. Mutat Res. 2011;727(3):55–61.
   PubMed Web of Science ®Google Scholar
• Anzola M, Cuevas N, Lopez-Martinez M, et al. p16INK4A gene alterations are not a prognostic indicator for survival in patients with hepatocellular carcinoma undergoing curative hepatectomy. J Gastroenterol Hepatol. 2004;19(4):397–405.
   PubMed Web of Science ®Google Scholar
• Herath NI, Leggett BA, MacDonald GA. Review of genetic and epigenetic alterations in hepatocarcinogenesis. J Gastroenterol Hepatol. 2006;21(1 Pt 1):15–21.
   PubMed Web of Science ®Google Scholar
• Crowley E, Di Nicolantonio F, Loupakis F, et al. Liquid biopsy: monitoring cancer-genetics in the blood. Nat Rev Clin Oncol. 2013;10(8):472–484.
   PubMed Web of Science ®Google Scholar
• Thakur BK, Zhang H, Becker A, and others. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res. 2014;24(6):766–769.
   PubMed Web of Science ®Google Scholar
• Wong IH, Lo YM, Yeo W, et al. Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients. Clin Cancer Res. 2000;6(9):3516–3521.
   PubMed Web of Science ®Google Scholar
• Wang J, Qin Y, Li B, et al. Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients. Clin Biochem. 2006;39(4):344–348.
   PubMed Web of Science ®Google Scholar
• Chan KC, Lai PB, Mok TS, et al. Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma. Clin Chem. 2008;54(9):1528–1536.
   PubMed Web of Science ®Google Scholar
• Elshimali YI, Khaddour H, Sarkissyan M, et al. The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients. Int J Mol Sci. 2013;14(9):18925–18958.
   PubMed Web of Science ®Google Scholar
• Chan KC, Jiang P, Chan CW, and others. Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing. Proc Natl Acad Sci USA. 2013;110(47):18761–18768.
   PubMed Web of Science ®Google Scholar
• Li F, Fan YC, Gao S, et al. Methylation of serum insulin-like growth factor-binding protein 7 promoter in hepatitis B virus-associated hepatocellular carcinoma. Genes Chromosomes Cancer. 2014;53(1):90–97.
   PubMed Web of Science ®Google Scholar
• Landberg G, Ostlund H, Nielsen NH, et al. Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors. Oncogene. 2001;20(27):3497–3505.
   PubMed Web of Science ®Google Scholar
• Ruan WJ, Lin J, Xu EP, and others. IGFBP7 plays a potential tumor suppressor role against colorectal carcinogenesis with its expression associated with DNA hypomethylation of exon 1. J Zhejiang Univ Sci B. 2006;7(11):929–932.
   PubMedGoogle Scholar
• Bruix J, Sherman M, American Association for the Study of Liver D. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–1022.
   PubMed Web of Science ®Google Scholar
• Yuan RH, Jeng YM, Pan HW, et al. Overexpression of KIAA0101 predicts high stage, early tumor recurrence, and poor prognosis of hepatocellular carcinoma. Clin Cancer Res. 2007;13(18 Pt 1):5368–5376.
   PubMed Web of Science ®Google Scholar
• Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50(3):661–662.
   PubMed Web of Science ®Google Scholar
• Smith P, Nicholson LJ, Syed N, et al. Epigenetic inactivation implies independent functions for insulin-like growth factor binding protein (IGFBP)-related protein 1 and the related IGFBPL1 in inhibiting breast cancer phenotypes. Clin Cancer Res. 2007;13(14):4061–4068.
   PubMed Web of Science ®Google Scholar
• Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol. 1997;12(9–10):S294–S308.
   PubMed Web of Science ®Google Scholar
• Villanueva A, Hoshida Y, Battiston C, and others. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology. 2011;140(5):1501–12.e2.
   PubMed Web of Science ®Google Scholar
• Bruix J, Boix L, Sala M, et al. Focus on hepatocellular carcinoma. Cancer Cell. 2004;5(3):215–219.
   PubMed Web of Science ®Google Scholar
• Tsai SM, Lin SK, Lee KT, et al. Evaluation of redox statuses in patients with hepatitis B virus-associated hepatocellular carcinoma. Ann Clin Biochem. 2009;46(Pt 5):394–400.
   PubMedGoogle Scholar
• Nair J, Srivatanakul P, Haas C, et al. High urinary excretion of lipid peroxidation-derived DNA damage in patients with cancer-prone liver diseases. Mutat Res. 2010;683(1–2):23–28.
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhao Y, Wang H, et al. Association between metabolic abnormalities and HBV related hepatocellular carcinoma in Chinese: a cross-sectional study. Nutr J. 2011;10:49.
   PubMed Web of Science ®Google Scholar
• Marra M, Sordelli IM, Lombardi A, and others. Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview. J Transl Med. 2011;9:171.
   PubMed Web of Science ®Google Scholar
• Nishida N, Kudo M. Oxidative stress and epigenetic instability in human hepatocarcinogenesis. Dig Dis. 2013;31(5–6):447–453.
   PubMed Web of Science ®Google Scholar
• Lim SO, Gu JM, Kim MS, et al. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology. 2008;135(6):2128–40, 2140.e1.
   PubMed Web of Science ®Google Scholar
• Wongpaiboonwattana W, Tosukhowong P, Dissayabutra T, et al. Oxidative stress induces hypomethylation of LINE-1 and hypermethylation of the RUNX3 promoter in a bladder cancer cell line. Asian Pac J Cancer Prev. 2013;14(6):3773–3778.
   PubMedGoogle Scholar
• Halliwell B. Oxidative stress and cancer: have we moved forward? Biochem J. 2007;401(1):1–11.
   PubMed Web of Science ®Google Scholar
• Unsal V, Belge-Kurutaş E. Experimental hepatic carcinogenesis: oxidative stress and natural antioxidants. Maced J Med Sci. 2017;5(5):686–691.
   Google Scholar
• Cheng SB, Liu HT, Chen SY, et al. Changes of oxidative stress, glutathione, and its dependent antioxidant enzyme activities in patients with hepatocellular carcinoma before and after tumor resection. PLoS ONE. 2017;12(1):e0170016.
   PubMed Web of Science ®Google Scholar
• Kang KA, Zhang R, Kim GY, et al. Epigenetic changes induced by oxidative stress in colorectal cancer cells: methylation of tumor suppressor RUNX3. Tumour Biol. 2012;33(2):403–412.
   PubMedGoogle Scholar
• O’Hagan HM, Wang W, Sen S, et al. Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands. Cancer Cell. 2011;20(5):606–619.
   PubMed Web of Science ®Google Scholar
• Stoyanov E, Ludwig G, Mizrahi L, et al. Chronic liver inflammation modifies DNA methylation at the precancerous stage of murine hepatocarcinogenesis. Oncotarget. 2015;6(13):11047–11060.
   PubMedGoogle Scholar
• Mizuno S, Chijiwa T, Okamura T, et al. Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood. 2001;97(5):1172–1179.
   PubMed Web of Science ®Google Scholar
• Kanai Y, Ushijima S, Kondo Y, et al. DNA methyltransferase expression and DNA methylation of CPG islands and pericentromeric satellite regions in human colorectal and stomach cancers. Int J Cancer. 2001;91(2):205–212.
   PubMed Web of Science ®Google Scholar
• Alsina AE, Nakshabandi A, Makris AM, et al. Liver transplantation for hepatocellular carcinoma in Puerto Ricans: underutilization of a curative therapy. PR Health Sci J. 2014;33(4):170–176.
   PubMed Web of Science ®Google Scholar
• Schlageter M, Terracciano LM, D’Angelo S, et al. Histopathology of hepatocellular carcinoma. World J Gastroenterol. 2014;20(43):15955–15964.
   PubMed Web of Science ®Google Scholar
• Colombo M, Sangiovanni A. Treatment of hepatocellular carcinoma: beyond international guidelines. Liver Int. 2015;35(Suppl1):129–138.
   Web of Science ®Google Scholar
• Poon RT, Fan ST, Ng IO, et al. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 2000;89(3):500–507.
   PubMed Web of Science ®Google Scholar
• Shah SA, Greig PD, Gallinger S, et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg. 2006;202(2):275–283.
   PubMed Web of Science ®Google Scholar
• Ibrahim S, Roychowdhury A, Hean TK. Risk factors for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Am J Surg. 2007;194(1):17–22.
   PubMed Web of Science ®Google Scholar
• Stroun M, Maurice P, Vasioukhin V, et al. The origin and mechanism of circulating DNA. Ann NY Acad Sci. 2000;906:161–168.
   PubMed Web of Science ®Google Scholar
• Xu RH, Wei W, Krawczyk M, et al. Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma. Nat Mater. 2017;16(11):1155–1161.
   PubMed Web of Science ®Google Scholar
• Lu X, Zhao H, Yang H, and others. A prospective clinical study on early recurrence of hepatocellular carcinoma after hepatectomy. J Surg Oncol. 2009;100(6):488–493.
   PubMed Web of Science ®Google Scholar